Dallas, TX -- (SBWIRE) -- 10/06/2014 -- H1N1 influenza (zoonotic) is an infectious disease in humans caused by a variant of the swine H1N1 virus, known as H1N1v virus. The H1N1v virus is a contagious virus which infects nose, throat, and lungs. H1N1 virus is an RNA virus belonging to the Orthomyxoviridae family. Influenza A viruses infect different animal species such as humans, swine, birds, seals, and horses. Influenza A viruses can be subdivided on the basis of antigenicity of its surface glycoproteins neuraminidase and hemagglutinin. Hemagglutinin component is used by the virus to bind to host cell receptors. This facilitates viral entry into the host cell. Neuraminidase protein enzymatically cleaves terminal sialic acid residues from mucins, thereby allowing the virus to reach underlying cells in the respiratory tract. Elderly people, young children, and people with medical conditions including liver disorders, blood disorders, kidney disorders, chronic lung disease, asthma, and neurodevelopmental and neurological conditions are at a higher risk of getting infected. Influenza vaccines are administered for active immunization against influenza virus. This, in turn, confers protection against influenza disease. Vaccination of high-risk groups prevents unnecessary hospitalizations and premature deaths resulting due to influenza.
Analysts forecast the Global H1N1 Vaccines market to grow at a CAGR of 5.40 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global H1N1 Vaccines market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of various vaccines administered to prevent human infection caused by H1N1 virus.
Global H1N1 Vaccines Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global H1N1 Vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Single User License USD 2500 Purchase Report @ http://www.reportsnreports.com/Purchase.aspx?name=300116.
Key Regions
Americas
APAC
EMEA
Key Vendors
AstraZeneca
GlaxoSmithKline
Novartis
Sanofi Pasteur
Other Prominent Vendors
Baxter International
bioCSL
Mitsubishi Tanabe Pharma
Protein Sciences Corporation
Serum Institute of India
Sinovac Biotech
Zydus Cadila
Inquire Before Buying @ http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=300116.
Market Driver
Increased Awareness on H1N1 Influenza
For a full, detailed list, view our report
Market Challenge
Antigenic Drift of H1N1v Virus
For a full, detailed list, view our report
Market Trend
Emergence of Quadrivalent Vaccines
For a full, detailed list, view our report
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?